Opiorphin
Brain & neurobiology
PreclinicalResearch is biochemical, ex vivo, and rodent analgesia work.
Laboratory, computational, ex vivo or animal model research is the main evidence base.
What is Opiorphin?
Opiorphin is an endogenous human peptide that modulates enkephalin degradation and is used in biochemical and rodent analgesia research; the catalogue entry denotes the research grade peptide for ex vivo and in vivo assays.
Which research context has Opiorphin been associated with?
Opiorphin is associated with biochemical and preclinical neuroscience research, including ex vivo assays and rodent analgesia studies investigating its opioid modulating properties and peptidase inhibition in pain related molecular pathways.
What documentation is available for Opiorphin?
Opiorphin: Batch documents are not yet linked on this site. For this endogenous opioid modulating peptide the checklist includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence or fragment confirmation; analytical HPLC/UPLC chromatogram with method and purity limit; peptide content and residual solvent/water data; and any bioassay or functional assay used for specification. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Opiorphin?
Opiorphin: Storage depends on the documented supplied presentation; for this endogenous opioid modulating peptide confirm dry/lyophilised versus solution form, solvent or buffer composition, concentration, pH stability, container closure compatibility and freeze/thaw resilience to mitigate proteolysis, adsorption and chemical degradation. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.